Skip to content

iRhythm Holdings, Inc. IRTC CMS — Revenue, net

Other product segments

Contracted third-party payors
$106.8M+27.4%
Customer A
$30.15M+13.1%
Non-contracted third-party payors
$11.04M+9.4%

Similar metrics at other companies

RadNet logo
RDNTMedicare — Total consolidated revenues
$137.18M+26.8%
Encompass Health Corporation logo
EHCMedicare — Net operating revenues
$1.04B+6.5%
Tenet Healthcare logo
THCMedicare — Net operating revenues
$565M+3.1%
Universal Health Services logo
UHSManaged Medicare — Revenue
$550.1M+5.7%
Alignment Healthcare logo
ALHCCMS Subsidies — Proceeds From Subsidies
$17.09M+165%
Centene logo
CNCMedicare — Total revenues
$10.33B+17.9%

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.44B+16.0%
Enterprise value$3.27B+21.8%
P/S4.4×-0.4×

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's cms — revenue, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's CMS — revenue, net?
iRhythm Holdings, Inc. (IRTC) reported CMS — revenue, net of $51.39M in Q1 2026.
What does CMS — revenue, net mean?
This metric represents the total net revenue generated from services provided to patients covered under Centers for Medicare & Medicaid Services programs. It reflects the company's ability to monetize its diagnostic offerings within the government-funded healthcare sector. Monitoring this figure helps investors assess the company's exposure to public payer reimbursement rates and the scale of its adoption within the Medicare population.